Cited by 4

The DOI matches its Crossref record.

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms

Uslu Bıçak, İldeniz, Tokcan, Berkay, Yavuz, Akif Selim, Tokdemir, Selçuk Sözer·2023·Turkish Journal of Hematology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4274/tjh.galenos.2022.2022.0343

Cites

Statistics

Figures

Figure 1 Fluorescence‐activated cell sorting (FACS) plot of peripheral blood mononuclear cells of a patient (P29) with Philadelphia chromosome-negative Ph– myeloproliferative neoplasm with polycythemia vera using gold nanoparticle probes. For all analyses, the main population of cells was gated excluding dead and fractured cells. After settings were completed for the background and control probes, including uptake fluorescence, analysis and sorting of the gold nanoparticle‐treated cells were performed according to their signals in channels of FL‐2 for JAK2V617F‐CY3 and FL‐4 for JAK2 wild‐type (wt)‐CY5 transcripts. The FACS of the gold nanoparticle-treated cells was performed in four quadrants: JAK2V617F–JAK2wt‐ for the negative control, JAK2V617F+JAK2wt– for JAK2V617F mutant mRNA, JAK2V617F+JAK2wt+ for both JAK2wt and JAK2V617F mRNA-positive cells, and JAK2V617F−JAK2wt+ for JAK2wt mRNA.
Figure 1 Fluorescence‐activated cell sorting (FACS) plot of peripheral blood mononuclear cells of a patient (P29) with Philadelphia chromosome-negative Ph– myeloproliferative neoplasm with polycythemia vera using gold nanoparticle probes. For all analyses, the main population of cells was gated excluding dead and fractured cells. After settings were completed for the background and control probes, including uptake fluorescence, analysis and sorting of the gold nanoparticle‐treated cells were performed according to their signals in channels of FL‐2 for JAK2V617F‐CY3 and FL‐4 for JAK2 wild‐type (wt)‐CY5 transcripts. The FACS of the gold nanoparticle-treated cells was performed in four quadrants: JAK2V617F–JAK2wt‐ for the negative control, JAK2V617F+JAK2wt– for JAK2V617F mutant mRNA, JAK2V617F+JAK2wt+ for both JAK2wt and JAK2V617F mRNA-positive cells, and JAK2V617F−JAK2wt+ for JAK2wt mRNA.CC BY-NC-ND · PubMed Central
Figure 2 Relative c-MYC gene expression analysis of (A) mononuclear cells (p=0.01, Mann-Whitney U), (B) multipotent progenitor cells (MPPs, CD133+CD34+) (p>0.05, Mann-Whitney U), (C) erythro-myeloid restricted progenitors (EMPs, CD133-CD34+) (p=0.02 Mann-Whitney U), (D) hematopoietic and endothelial progenitor cells (HSCs/EPCs, CD133–CD34–) (p=0.01, Mann-Whitney U), and (E) endothelial progenitor cells (EPCs, CD133+CD34-) (p=0.03, Mann-Whitney U) in samples from 14 patients with myeloproliferative neoplasms and 5 control samples of cord blood. Relative c-MYC gene expressions were calculated with the formula 2-∆Ct = 2-(CTExample – CTReferance) applying ACTB as a reference gene. GraphPad Prism 8.0 software was used for the statistical analysis of gene expression data; in each figure, the standard deviation of the mean (SD) is shown with a bar; **p< 0.05.
Figure 2 Relative c-MYC gene expression analysis of (A) mononuclear cells (p=0.01, Mann-Whitney U), (B) multipotent progenitor cells (MPPs, CD133+CD34+) (p>0.05, Mann-Whitney U), (C) erythro-myeloid restricted progenitors (EMPs, CD133-CD34+) (p=0.02 Mann-Whitney U), (D) hematopoietic and endothelial progenitor cells (HSCs/EPCs, CD133–CD34–) (p=0.01, Mann-Whitney U), and (E) endothelial progenitor cells (EPCs, CD133+CD34-) (p=0.03, Mann-Whitney U) in samples from 14 patients with myeloproliferative neoplasms and 5 control samples of cord blood. Relative c-MYC gene expressions were calculated with the formula 2-∆Ct = 2-(CTExample – CTReferance) applying ACTB as a reference gene. GraphPad Prism 8.0 software was used for the statistical analysis of gene expression data; in each figure, the standard deviation of the mean (SD) is shown with a bar; **p< 0.05.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 1

  1. Kelley, N., & Trebilcock, M. J. (1998). The making of the mosaic: A history of Canadian immigration policy. University of Toronto Press.

Cited by

See all 4

Metadata

Authors
Uslu Bıçak, İ., Tokcan, B., Yavuz, A. S., & Tokdemir, S. S.
Venue
Turkish Journal of Hematology
Published
2023-03-03
Volume
40
Issue
1
Pages
28-36
ISSN
  • 1300-7777
  • 1308-5263
Cited by
4
References
0

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms. https://app.cochat.ai/papers/10.4274/tjh.galenos.2022.2022.0343
The paper
Uslu Bıçak, İ., Tokcan, B., Yavuz, A. S., & Tokdemir, S. S. (2023). Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms. Turkish Journal of Hematology. https://doi.org/10.4274/tjh.galenos.2022.2022.0343